Immunosuppressive therapy and clinical evolution in forty-nine patients with antineutrophil cytoplasmic antibody-associated glomerulonephritis

Annals of the New York Academy of Sciences

Volumn 1051, Issue , 2005, Pages 597-605

  Kokolina, Elisabeth ^a,b   Alexopoulos, E ^a   Dimitriadis, C ^a   Vainas, A ^a   Giamalis, P ^a   Papagianni, A ^a   Ekonomidou, D ^a   Memmos, D ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b NONE   (Greece)

Author keywords

ANCA associated glomerulonephritis; Immunosuppressive therapy; Renal pathology; Renal survival

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; PLASMAPHERESIS; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 25444448207     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1361.104     Document Type: Conference Paper

References (17)

1. DAVIES, D.J., J.E. MORAN, J.F. NIALL & G.B. RYAN. 1982. Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology? Br. Med. J. 285: 606.
2. VAN DER WOUDE, F.J., N. RASMUSSEN, S. LOBATTO, et al. 1985. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1: 425-429.
3. FALK, R.J. & J.C. JENETTE. 1988. Antineutrophil cytoplasmic antibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic crescentic glomerulonephritis. N. Engl. J. Med. 318: 1651-1657.
4. KALLENBERG, C.G., E. BROUWER, J.J. WEENING & J.W. TERVAERT. 1994. Antineutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int. 46: 1-15.
5. SAVAGE, C.O.S., L. HARPER, P. COCKWELL, et al. 2000. Vasculitis. Br. Med. J. 320: 1325-1328.
6. COHEN TERVAERT, J., R. GOLDSCHMEDING, J.D. ELEMA, et al. 1990. Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum. 33: 1264-1272.
7. GIRARD, T., A. MAHR, L.H. NOEL, et al. 2001. Are antineutrophil cytoplasmic antibodies a marker of predictive of relapse in Wegener's granulomatosis? A prospective study. Arthritis Rheum 40: 147-151.
8. XIAO, H., P. HEERINGA, P. HU, et al. 2002. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J. Clin. Invest. 110: 955-963.
9. HEERINGA, P. & J.W. COHEN TERVAERT. 2004. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic? Kidney Int. 65: 1564-1567.
10. BAJEMA, I.M., E.C. HAGEN, B. HANSEN, et al. 1996. Scoring renal histopathology in systemic vasculitis: an international survey study of inter and intra observer agreement. Nephrol. Dial. Transplant. 11: 1989-1995.
11. HOFFMAN, G.S., G.S. KERR, R.Y. LEAVITT, et al. 1992. Wegener's granulomatosis an analysis of 158 patients. Ann. Intern. Med. 116: 488-498.
12. KAMESH, L., L. HARPER & C.O.S. SAVAGE. 2002. ANCA-positive vasculitis. J. Am. Soc. Nephrol. 13: 1953-1960.
13. WESTMAN, K.W.A., P.G. BYGREN, H. OLSSON, et al. 1998. Relapse rate, renal survival and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J. Am. Soc. Nephrol. 7: 842-852.
14. NACHMAN, P.H., S. HOGAN, J.C. JENNETTE & R.J. FALK. 1996. Treatment response and relapse in ANCA-associated microscopic polyangiitis and glomerulonephritis. J. Am. Soc. Nephrol. 7: 33-39.
15. HOGAN, S., P.H. NACHMAN, A.S. WILKMAN, et al. 1996. Prognostic markers in patients with antineutrophil cytoplasmic antibody-associated microscopic polyangiitis and glomerulonephritis. J. Am. Soc. Nephrol. 7: 23-32.
16. FRANSSEN, C.F.M., C.A. STEGEMAN, W.W. OOST-KORT, et al. 1998. Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis. J. Am. Soc. Nephrol. 9: 1915-1923.
17. BAJEMA, I.M., E.C. HAGEN, J. HERMANS, et al. 1999. Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int. 56: 1751-1758.